Clinical trial
Refractive and Biometric Outcome Following Intravitreal Injection of Ranibizumab in Retinopathy of Prematurity: Long -Term Study
NCT04537065 is registered in ClinicalTrials.gov with Ameera Gamal Abdelhameed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Refractive and Biometric Outcome Following Intravitreal Injection of Ranibizumab in Retinopathy of Prematurity: Long -Term Study
- Lead sponsor
- Ameera Gamal Abdelhameed
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2018
- Completion date
- September 1, 2018
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.